The American Journal of Managed Care

Sivelestat Lowers ARDS Risk, Mortality Following Cardiovascular Surgery

Sivelestat significantly reduced the incidence of postoperative ARDS, lowered 90-day mortality, and suppressed inflammatory biomarkers linked to lung injury.